Mikkel Viltoft

Novozymes South Asia Pvt Ltd. develops and produces enzyme products. The company was founded in 1983 and is headquartered in Bangalore, India.

Novozymes Bioindustrial China A/S invests in research and development as well as production of biotechnological products and processes. The company was founded on January 1, 1999 and is headquartered in Bagsvaerd, Denmark.

Novozymes Biopharma DK A/S engages in the wholesale of pharmaceuticals and medical article. The firm operates and invests in research, development, production, and trade in biological solutions, including pharmaceuticals, and biotechnology products and processes.The company was founded on May 29, 2006 and is headquartered in Bagsvaerd, Denmark.

Novozymes BioloAg A/S provides research and development for biotechnology products and processes. It participates in The BioAg Alliance to commercialize BioAg assets and competencies within microbial research, development, and production. The company was founded on October 22, 2007 and is headquartered in Bagsvaerd, Denmark.

Part of Novonesis A/S, Novozymes Deutschland GmbH is a German company that develops bacterial and virus vaccines, toxoids, and analogous products. The company is based in Bad Kreuznach, Germany. The CEOs are Mikkel Viltoft and Randi Camilla Kinch Jensen. The company was founded in 2003.

Novozymes France SAS develops and manufactures biopharmaceutical products. The company was founded on October 8, 1976 and is headquartered in Le Pecq, France.

Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark.